Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Accounts Payables (2019 - 2025)

Pulmonx has reported Accounts Payables over the past 7 years, most recently at $3.9 million for Q4 2025.

  • Quarterly Accounts Payables rose 2.04% to $3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Dec 2025, up 2.04% year-over-year, with the annual reading at $3.9 million for FY2025, 2.04% up from the prior year.
  • Accounts Payables was $3.9 million for Q4 2025 at Pulmonx, down from $6.4 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $6.6 million in Q2 2025 and troughed at $1.5 million in Q4 2023.
  • The 5-year median for Accounts Payables is $3.0 million (2023), against an average of $3.3 million.
  • Year-over-year, Accounts Payables tumbled 40.28% in 2022 and then soared 155.64% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $1.6 million in 2021, then increased by 11.13% to $1.8 million in 2022, then dropped by 14.85% to $1.5 million in 2023, then soared by 155.64% to $3.8 million in 2024, then rose by 2.04% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Accounts Payables are $3.9 million (Q4 2025), $6.4 million (Q3 2025), and $6.6 million (Q2 2025).